November 14, 2019 by Chain Drug Review
NACDS, Steve Anderson, Substance use disorder (SUD) treatment
Featured Articles, Leading Headlines, Pharmacy
ARLINGTON, Va.– Substance use disorder (SUD) treatment could benefit from pharmacists’ accessibility and expertise, the National Association of Chain Drug Stores (NACDS) wrote in detailed letters to 15 Medicaid program directors. NACDS also called for action on policy recommendations designed to help prevent opioid abuse and addiction, while caring for those in pain. NACDS made
November 8, 2019 by Chain Drug Review
Discount Drug Mart, NACDS, U.S. Rep. Bob Gibbs
Leading Headlines, Retail News
ARLINGTON, Va.— U.S. Rep. Bob Gibbs (R, Ohio) visited the Ashland, Ohio, Discount Drug Mart to discuss pharmacy benefit manager issues – including the need for direct and indirect remuneration (DIR) fee relief. Rep. Gibbs also presented Discount Drug Mart with a proclamation recognizing the company’s 50th year in business. Discount Drug Mart – an
November 4, 2019 by Chain Drug Review
NACDS, NACDS president and chief executive officer Steven Anderson
News, November 4, 2019
ARLINGTON, Va. — The pain management and opioid policies advanced by the National Association of Chain Drug Stores can help guide the federal government’s action plan to prevent and treat opioid addiction, according to the association, which recently conveyed this message to the Centers for Medicare and Medicaid Services (CMS). NACDS submitted comments to CMS
October 31, 2019 by Chain Drug Review
Don Bell, Mary Ellen Kleiman, NACDS, Sandra Guckian, Steven Anderson, Tom O'Donnell
Leading Headlines, Pharmacy
ARLINGTON, Va. — The National Association of Chain Drug Stores (NACDS) has elevated and enhanced three key functions to integrate with NACDS’ campaign-style approach to issue advocacy. Federal government affairs, state government affairs, and public policy now will operate as dedicated and distinct, yet highly collaborative, functions in support of NACDS’ four campaigns established by
October 25, 2019 by Chain Drug Review
NACDS, NACDS president and chief executive officer Steven Anderson, National Prescription Drug Take-Back Day
Featured Articles, Leading Headlines, Pharmacy
ARLINGTON, Va. – National Prescription Drug Take Back Day is a chance to help keep opioids out of the wrong hands and to raise awareness of other critical resources that help keep patients, families and communities safe, the National Association of Chain Drug Stores (NACDS) said Friday. The Drug Enforcement Administration (DEA) and its partners showcase this
October 21, 2019 by David Pinto
NACDS
October 21, 2019, Opinion
Among the retail trade organizations, one association has emerged as the driving force of the industry it serves, the catalyst for inclusion, and the prime determinator of the directions mass retailing embarks on and the success the industry is achieving in taking stances and making lasting impressions. That organization is the National Association of Chain
September 24, 2019 by Chain Drug Review
American Pharmacists Month, NACDS, Steven Anderson, World Pharmacists Day
Leading Headlines, Pharmacy
ARLINGTON, Va. — With American Pharmacists Month observed in October, and World Pharmacists Day observed on September 25, NACDS is distributing its 30-second message that reflects pharmacies’ and pharmacists’ commitment to serving as part of the solution to opioid abuse and to pain care. NACDS president and chief executive officer Steven Anderson said, “Opioid abuse
September 12, 2019 by Chain Drug Review
DIR fees, NACDS
Leading Headlines, Pharmacy
ARLINGTON, Va. — On a strong bipartisan basis, the chairman, ranking member, and an overwhelming majority of the Senate Finance Committee have asked the Trump Administration to do its part to close a Medicare regulation loophole – known as pharmacy direct and indirect remuneration (DIR) fees – that inflates patients’ out-of-pocket drug costs and that
August 26, 2019 by Chain Drug Review
NACDS, opioid abuse epidemic, Steven Anderson
Videos
August 26, 2019 by Chain Drug Review
2019 NACDS Total Store Expo (NACDS TSE), NACDS
Videos
https://www.youtube.com/watch?v=YIWuZaeZr1s
August 25, 2019 by Chain Drug Review
Chris Lane, NACDS, Steven Anderson, U.S. Senator John Kerry
Featured Articles, Leading Headlines, Pharmacy
BOSTON – “We have big issues. We have big ideas. So thank you for your role in addressing and advancing them at TSE.” With those words, National Association of Chain Drug Stores (NACDS) chairman of the board Chris Lane, executive vice president of Wakefern Food Corp./ShopRite, summarized the NACDS Total Store Expo’s role in helping
July 31, 2019 by Chain Drug Review
DisposeRx, Drug Enforcement Administration's (DEA's) Automated Reports and Consolidated Ordering System (ARCOS), NACDS, opioid crisis, Steven Anderson, William Simpson
Leading Headlines, Pharmacy
SANFORD, N.C. — DisposeRx, a drug disposal company committed to eradicating the misuse of leftover medications in the home medicine cabinet, announced Wednesday its support and affirmation of a statement recently issued by the National Association of Chain Drug Stores (NACDS) regarding the key role of community pharmacies in helping to solve the opioid crisis.
July 26, 2019 by Chain Drug Review
direct and indirect remuneration (DIR) fee reform, Drug Pricing Reduction Act (PDPRA) of 2019, Iowa), NACDS, National Association of Chain Drug Stores, National Association of Specialty Pharmacy, National Community Pharmacists Association, Senate Finance Committee chairman Chuck Grassley (R
Featured Articles, Leading Headlines, Pharmacy
WASHINGTON – With the Senate Finance Committee holding a legislative markup today of the Prescription Drug Pricing Reduction Act (PDPRA) of 2019, eight associations noted initial bipartisan movement on direct and indirect remuneration (DIR) fee reform, but reiterated the need for swift and decisive action on this issue. Issuing a joint statement were: National Community
July 23, 2019 by Jeffrey Woldt
DIR Reform, NACDS, NACDS RxIMPACT, National Association of Chain Drug Store, Senate Finance Committee
Featured Articles, Leading Headlines, Pharmacy
WASHINGTON — With the Senate Finance Committee expected to begin making decisions on spending bills as early as today, the National Association of Chain Drug Stores has launched a telephone hotline — (866) DIR-RE4M — that pharmacy advocates can use to urge the inclusion of DIR fee relief in drug-pricing legislation. An NACDS RxImpact grassroots